(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LOOPLIGASE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LOOPLIGASE

ST13

US500000090199980

Class

1, 5

Filing

90199980

Registration

7697708

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

02/18/2025

Trademark type

Word

Nice classes

1, 5

Filing date

09/22/2020

Registration date

02/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2025

Last transaction

02/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

02/28/2024

First use in commerce

02/28/2024

Drawing code

4

Owner type

16

Owner location

Beverly, MA

Examiner

FAUCETTE, MAX CLIFFORD STE

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Qiagen Beverly, LLC

Representatives

Randolph E. Digges, III RANKIN, HILL & CLARK, LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiochemical and biotechnological diagnostic preparations for scientific purposesbuffer solutions for the markingseparatingisolatingamplifyingcloningsequencing and analysis of biopolymersin particular nucleic acidsin particular reagentsenzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use featuring chemicals for the markingseparatingisolatingamplifyingcloningsequencing and analysis of biopolymersin particular nucleic acidsin particular comprising reagentsenzymes and buffer solutions for nucleic acid amplification and cloning

Class 5

Diagnostic preparations for medical and veterinary purposesdiagnostics preparations for the markingseparatingisolatingamplifyingcloningsequencing and analysis of biopolymersnucleic acids; diagnostic reagentsenzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemicalbiochemical and biotechnological diagnostic preparations for medical and veterinary purposesreagentsenzymes and buffer solutions for the markingseparatingisolatingamplifyingcloningsequencing and analysis of biopolymersnucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposespreparations for markingseparatingisolatingamplifyingcloningsequencing and analysis of biopolymersnucleic acids; diagnostic kits containing reagentsenzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes

Publications

History of USPTO decisions and trademark events.

45 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/24/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/24/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/26/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/26/2024

IUAF

USE AMENDMENT FILED

10/11/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/11/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/08/2024

EX5G

SOU EXTENSION 5 GRANTED

03/07/2024

EXT5

SOU EXTENSION 5 FILED

03/07/2024

EEXT

SOU TEAS EXTENSION RECEIVED

03/07/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/13/2023

EX4G

SOU EXTENSION 4 GRANTED

09/11/2023

EXT4

SOU EXTENSION 4 FILED

09/11/2023

EEXT

SOU TEAS EXTENSION RECEIVED

09/11/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/07/2023

EX3G

SOU EXTENSION 3 GRANTED

03/03/2023

EXT3

SOU EXTENSION 3 FILED

03/03/2023

EEXT

SOU TEAS EXTENSION RECEIVED

03/03/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/12/2022

EX2G

SOU EXTENSION 2 GRANTED

10/10/2022

EXT2

SOU EXTENSION 2 FILED

10/10/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/10/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/22/2022

EX1G

SOU EXTENSION 1 GRANTED

03/18/2022

EXT1

SOU EXTENSION 1 FILED

03/18/2022

EEXT

SOU TEAS EXTENSION RECEIVED

03/18/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/12/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/17/2021

PUBO

PUBLISHED FOR OPPOSITION

08/17/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/28/2021

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

07/14/2021

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

07/09/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/01/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/08/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/08/2021

ALIE

ASSIGNED TO LIE

06/07/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/11/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/15/2021

GNRT

NON-FINAL ACTION E-MAILED

02/15/2021

CNRT

NON-FINAL ACTION WRITTEN

02/15/2021

DOCK

ASSIGNED TO EXAMINER

02/08/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/30/2020

NWAP

NEW APPLICATION ENTERED

09/25/2020

Continuous trademark protection

Get notified about every new filing that threatens LOOPLIGASE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.